Tags

Type your tag names separated by a space and hit enter

Gene Editing for Duchenne Muscular Dystrophy Using the CRISPR/Cas9 Technology: The Importance of Fine-tuning the Approach.
Mol Ther. 2016 11; 24(11):1888-1889.MT

Authors+Show Affiliations

Centre de Recherche du CHU de Québec-Université Laval, Quebec, Quebec, Canada. Electronic address: Jacques-P.Tremblay@crchul.ulaval.ca.Centre de Recherche du CHU de Québec-Université Laval, Quebec, Quebec, Canada.Centre de Recherche du CHU de Québec-Université Laval, Quebec, Quebec, Canada.Centre de Recherche du CHU de Québec-Université Laval, Quebec, Quebec, Canada.

Pub Type(s)

Letter

Language

eng

PubMed ID

27916992

Citation

Tremblay, Jacques P., et al. "Gene Editing for Duchenne Muscular Dystrophy Using the CRISPR/Cas9 Technology: the Importance of Fine-tuning the Approach." Molecular Therapy : the Journal of the American Society of Gene Therapy, vol. 24, no. 11, 2016, pp. 1888-1889.
Tremblay JP, Iyombe-Engembe JP, Duchêne B, et al. Gene Editing for Duchenne Muscular Dystrophy Using the CRISPR/Cas9 Technology: The Importance of Fine-tuning the Approach. Mol Ther. 2016;24(11):1888-1889.
Tremblay, J. P., Iyombe-Engembe, J. P., Duchêne, B., & Ouellet, D. L. (2016). Gene Editing for Duchenne Muscular Dystrophy Using the CRISPR/Cas9 Technology: The Importance of Fine-tuning the Approach. Molecular Therapy : the Journal of the American Society of Gene Therapy, 24(11), 1888-1889. https://doi.org/10.1038/mt.2016.191
Tremblay JP, et al. Gene Editing for Duchenne Muscular Dystrophy Using the CRISPR/Cas9 Technology: the Importance of Fine-tuning the Approach. Mol Ther. 2016;24(11):1888-1889. PubMed PMID: 27916992.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Gene Editing for Duchenne Muscular Dystrophy Using the CRISPR/Cas9 Technology: The Importance of Fine-tuning the Approach. AU - Tremblay,Jacques P, AU - Iyombe-Engembe,Jean-Paul, AU - Duchêne,Benjamin, AU - Ouellet,Dominique L, PY - 2016/12/6/entrez PY - 2016/12/6/pubmed PY - 2018/9/14/medline SP - 1888 EP - 1889 JF - Molecular therapy : the journal of the American Society of Gene Therapy JO - Mol. Ther. VL - 24 IS - 11 SN - 1525-0024 UR - https://www.unboundmedicine.com/medline/citation/27916992/Gene_Editing_for_Duchenne_Muscular_Dystrophy_Using_the_CRISPR/Cas9_Technology:_The_Importance_of_Fine_tuning_the_Approach_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1525-0016(16)45442-0 DB - PRIME DP - Unbound Medicine ER -